Association between nonsteroidal anti-inflammatory drugs and colorectal cancer: A population-based case-control study

Chun Nan Kuo, Jen Jung Pan, Ya Wen Huang, Hui Ju Tsai, Wei Chiao Chang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: COX-2 overexpression may contribute to colorectal cancer occurrence. Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) can reduce colorectal cancer recurrence, but the efficacy of primary prevention in Asian populations is still elusive. Thus, we examined the primary preventive efficacy of aspirin and NSAIDs on colorectal cancer incidence in Taiwan. Methods: A nested case-control study was conducted using the National Health Insurance Research Database (NHIRD) in Taiwan. We identified patients with diagnosis of colorectal cancer from 2005 to 2013 in the Registry of Catastrophic Illness Patient Database. We selected patients without colorectal cancer from the Longitudinal Health Insurance Database as the controls and matched them with cases. NSAID exposure was defined as at least two prescriptions 13 to 48 months prior to the index date. Conditional logistic regression models were performed to evaluate the association between NSAID use and colorectal cancer. Results: A total of 65,208 colorectal cancer cases and 65,208 matched controls were identified. Patients with aspirin use had a lower risk of colorectal cancer compared with nonusers [adjusted OR (AOR) = 0.94, 95% confidence interval (CI) = 0.90-0.99]. NSAID use was associated with lower incidence of colorectal cancer (AOR = 0.96; 95% CI = 0.92-1.00). When examining colon or rectal cancer, similar decreased risks were observed. Patients taking more cumulative days of NSAIDs use tended to experience a more protective effect on colorectal cancer, but no dose-response effects were noted. Conclusions: Aspirin and NSAIDs were associated with a reduced risk of colorectal cancer development among a study cohort in an Asian population. Impact: This study provided a possible chemoprevention for colorectal cancer in an Asian population.

Original languageEnglish
Pages (from-to)737-745
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume27
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Case-Control Studies
Colorectal Neoplasms
Anti-Inflammatory Agents
Pharmaceutical Preparations
Population
Aspirin
Databases
Taiwan
Catastrophic Illness
Logistic Models
Confidence Intervals
Incidence
Chemoprevention
National Health Programs
Primary Prevention
Health Insurance
Rectal Neoplasms
Colonic Neoplasms
Prescriptions
Registries

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Association between nonsteroidal anti-inflammatory drugs and colorectal cancer : A population-based case-control study. / Kuo, Chun Nan; Pan, Jen Jung; Huang, Ya Wen; Tsai, Hui Ju; Chang, Wei Chiao.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 27, No. 7, 01.07.2018, p. 737-745.

Research output: Contribution to journalArticle

@article{b16231f390b2403c8d84ddb9e83fb280,
title = "Association between nonsteroidal anti-inflammatory drugs and colorectal cancer: A population-based case-control study",
abstract = "Background: COX-2 overexpression may contribute to colorectal cancer occurrence. Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) can reduce colorectal cancer recurrence, but the efficacy of primary prevention in Asian populations is still elusive. Thus, we examined the primary preventive efficacy of aspirin and NSAIDs on colorectal cancer incidence in Taiwan. Methods: A nested case-control study was conducted using the National Health Insurance Research Database (NHIRD) in Taiwan. We identified patients with diagnosis of colorectal cancer from 2005 to 2013 in the Registry of Catastrophic Illness Patient Database. We selected patients without colorectal cancer from the Longitudinal Health Insurance Database as the controls and matched them with cases. NSAID exposure was defined as at least two prescriptions 13 to 48 months prior to the index date. Conditional logistic regression models were performed to evaluate the association between NSAID use and colorectal cancer. Results: A total of 65,208 colorectal cancer cases and 65,208 matched controls were identified. Patients with aspirin use had a lower risk of colorectal cancer compared with nonusers [adjusted OR (AOR) = 0.94, 95{\%} confidence interval (CI) = 0.90-0.99]. NSAID use was associated with lower incidence of colorectal cancer (AOR = 0.96; 95{\%} CI = 0.92-1.00). When examining colon or rectal cancer, similar decreased risks were observed. Patients taking more cumulative days of NSAIDs use tended to experience a more protective effect on colorectal cancer, but no dose-response effects were noted. Conclusions: Aspirin and NSAIDs were associated with a reduced risk of colorectal cancer development among a study cohort in an Asian population. Impact: This study provided a possible chemoprevention for colorectal cancer in an Asian population.",
author = "Kuo, {Chun Nan} and Pan, {Jen Jung} and Huang, {Ya Wen} and Tsai, {Hui Ju} and Chang, {Wei Chiao}",
year = "2018",
month = "7",
day = "1",
doi = "10.1158/1055-9965.EPI-17-0876",
language = "English",
volume = "27",
pages = "737--745",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Association between nonsteroidal anti-inflammatory drugs and colorectal cancer

T2 - A population-based case-control study

AU - Kuo, Chun Nan

AU - Pan, Jen Jung

AU - Huang, Ya Wen

AU - Tsai, Hui Ju

AU - Chang, Wei Chiao

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background: COX-2 overexpression may contribute to colorectal cancer occurrence. Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) can reduce colorectal cancer recurrence, but the efficacy of primary prevention in Asian populations is still elusive. Thus, we examined the primary preventive efficacy of aspirin and NSAIDs on colorectal cancer incidence in Taiwan. Methods: A nested case-control study was conducted using the National Health Insurance Research Database (NHIRD) in Taiwan. We identified patients with diagnosis of colorectal cancer from 2005 to 2013 in the Registry of Catastrophic Illness Patient Database. We selected patients without colorectal cancer from the Longitudinal Health Insurance Database as the controls and matched them with cases. NSAID exposure was defined as at least two prescriptions 13 to 48 months prior to the index date. Conditional logistic regression models were performed to evaluate the association between NSAID use and colorectal cancer. Results: A total of 65,208 colorectal cancer cases and 65,208 matched controls were identified. Patients with aspirin use had a lower risk of colorectal cancer compared with nonusers [adjusted OR (AOR) = 0.94, 95% confidence interval (CI) = 0.90-0.99]. NSAID use was associated with lower incidence of colorectal cancer (AOR = 0.96; 95% CI = 0.92-1.00). When examining colon or rectal cancer, similar decreased risks were observed. Patients taking more cumulative days of NSAIDs use tended to experience a more protective effect on colorectal cancer, but no dose-response effects were noted. Conclusions: Aspirin and NSAIDs were associated with a reduced risk of colorectal cancer development among a study cohort in an Asian population. Impact: This study provided a possible chemoprevention for colorectal cancer in an Asian population.

AB - Background: COX-2 overexpression may contribute to colorectal cancer occurrence. Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) can reduce colorectal cancer recurrence, but the efficacy of primary prevention in Asian populations is still elusive. Thus, we examined the primary preventive efficacy of aspirin and NSAIDs on colorectal cancer incidence in Taiwan. Methods: A nested case-control study was conducted using the National Health Insurance Research Database (NHIRD) in Taiwan. We identified patients with diagnosis of colorectal cancer from 2005 to 2013 in the Registry of Catastrophic Illness Patient Database. We selected patients without colorectal cancer from the Longitudinal Health Insurance Database as the controls and matched them with cases. NSAID exposure was defined as at least two prescriptions 13 to 48 months prior to the index date. Conditional logistic regression models were performed to evaluate the association between NSAID use and colorectal cancer. Results: A total of 65,208 colorectal cancer cases and 65,208 matched controls were identified. Patients with aspirin use had a lower risk of colorectal cancer compared with nonusers [adjusted OR (AOR) = 0.94, 95% confidence interval (CI) = 0.90-0.99]. NSAID use was associated with lower incidence of colorectal cancer (AOR = 0.96; 95% CI = 0.92-1.00). When examining colon or rectal cancer, similar decreased risks were observed. Patients taking more cumulative days of NSAIDs use tended to experience a more protective effect on colorectal cancer, but no dose-response effects were noted. Conclusions: Aspirin and NSAIDs were associated with a reduced risk of colorectal cancer development among a study cohort in an Asian population. Impact: This study provided a possible chemoprevention for colorectal cancer in an Asian population.

UR - http://www.scopus.com/inward/record.url?scp=85049646233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049646233&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-17-0876

DO - 10.1158/1055-9965.EPI-17-0876

M3 - Article

AN - SCOPUS:85049646233

VL - 27

SP - 737

EP - 745

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 7

ER -